P16-28. The first year: early correlates of long-term HIV progression

by Michael NL, Ganesan A, Mascola JR, Brodie T, Chattopadhyay PK, Roederer M
Published 2009-10-01

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

by Foulds K, Donaldson M, Freimuth W, Migone T, Pegu A, Roederer M, Nabel GJ
Published 2009-10-01

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses

by Riou C, Abrahams M, Mlisana K, Koup R, Roederer M, Karim S, de Bruyn G, Williamson C, Gray CM, Burgers WA
Published 2012-09-01

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues

by Liyanage NP, Pegu P, Gordon S, Cameron M, Foulds K, Doster M, Vaccari M, Koup R, Roederer M, Sékaly R, Franchini G
Published 2012-09-01

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)

by Nabel GJ, Mascola JR, Koup RA, Roederer M, Bailer RT, Nason MC, Holman LA, Gordon IJ, Enama ME, Novik L, Ledgerwood JE, Graham BS
Published 2009-10-01